Cargando…
Alteration of serum markers in COVID‐19 and implications on mortality
Autores principales: | Liu, Dan, Li, Ruyuan, Yu, Ruidi, Wang, Ya, Feng, Xinxia, Yuan, Yuan, Wang, Siyuan, Zeng, Shaoqing, Gao, Yue, Xu, Sen, Li, Huayi, Jiao, Xiaofei, Chi, Jianhua, Yu, Yang, Song, Chunyan, Jin, Ning, Cui, Pengfei, Liu, Jiahao, Zheng, Xu, Gong, Wenjian, Liu, Xingyu, Cai, Guangyao, Song, Jianming, Kwan, Susan Yuk‐Lin, Desai, Aakash, Li, Chunrui, Gao, Qinglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404578/ https://www.ncbi.nlm.nih.gov/pubmed/32696591 http://dx.doi.org/10.1002/ctm2.119 |
Ejemplares similares
-
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
por: Liu, Dan, et al.
Publicado: (2020) -
Immunity‐modulated sex disparity on COVID‐19 prognosis
por: Liu, Dan, et al.
Publicado: (2020) -
Immunological alternation in COVID-19 patients with cancer and its implications on mortality
por: Cai, Guangyao, et al.
Publicado: (2021) -
A real‐world study of glucocorticoid treatment in COVID‐19 patients with different disease severities
por: Jiao, Xiaofei, et al.
Publicado: (2020) -
Development and validation of an online model to predict critical COVID-19 with immune-inflammatory parameters
por: Gao, Yue, et al.
Publicado: (2021)